BioMarin Pharmaceutical Inc (BMRN) Return on equity 2016–2025
BioMarin Pharmaceutical Inc (BMRN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
5.7%FY2025 · since FY2016: -22.8% → 5.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.7% | -1.8 pp |
| FY2024 | 7.5% | +4.2 pp |
| FY2023 | 3.4% | +0.3 pp |
| FY2022 | 3.1% | +4.6 pp |
| FY2021 | -1.5% | -22.3 pp |
| FY2020 | 20.8% | +21.6 pp |
| FY2019 | -0.8% | +1.8 pp |
| FY2018 | -2.6% | +1.6 pp |
| FY2017 | -4.2% | +18.6 pp |
| FY2016 | -22.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice